219 related articles for article (PubMed ID: 31402276)
1. Serum 8-hydroxydeoxyguanosine, a marker of oxidative DNA damage, is associated with mortality independent of inflammation in chronic kidney disease.
Dai L; Watanabe M; Qureshi AR; Mukai H; Machowska A; Heimbürger O; Barany P; Lindholm B; Stenvinkel P
Eur J Intern Med; 2019 Oct; 68():60-65. PubMed ID: 31402276
[TBL] [Abstract][Full Text] [Related]
2. Oxidative DNA damage and mortality in hemodialysis and peritoneal dialysis patients.
Xu H; Watanabe M; Qureshi AR; Heimbürger O; Bárány P; Anderstam B; Eriksson M; Stenvinkel P; Lindholm B
Perit Dial Int; 2015; 35(2):206-15. PubMed ID: 24584621
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial 8-hydroxy-2'-deoxyguanosine and coronary artery disease in patients with type 2 diabetes mellitus.
Wang XB; Cui NH; Liu X; Liu X
Cardiovasc Diabetol; 2020 Feb; 19(1):22. PubMed ID: 32075646
[TBL] [Abstract][Full Text] [Related]
4. Not all inflammatory markers are linked to kidney function: results from a population-based study.
Pruijm M; Ponte B; Vollenweider P; Mooser V; Paccaud F; Waeber G; Marques-Vidal P; Burnier M; Bochud M
Am J Nephrol; 2012; 35(3):288-94. PubMed ID: 22398717
[TBL] [Abstract][Full Text] [Related]
5. Plasma Pentosidine and Its Association with Mortality in Patients with Chronic Kidney Disease.
Machowska A; Sun J; Qureshi AR; Isoyama N; Leurs P; Anderstam B; Heimburger O; Barany P; Stenvinkel P; Lindholm B
PLoS One; 2016; 11(10):e0163826. PubMed ID: 27701453
[TBL] [Abstract][Full Text] [Related]
6. Plasma S100A12 and soluble receptor of advanced glycation end product levels and mortality in chronic kidney disease Stage 5 patients.
Isoyama N; Leurs P; Qureshi AR; Bruchfeld A; Anderstam B; Heimburger O; Bárány P; Stenvinkel P; Lindholm B
Nephrol Dial Transplant; 2015 Jan; 30(1):84-91. PubMed ID: 25074436
[TBL] [Abstract][Full Text] [Related]
7. Association of C-reactive protein, tumor necrosis factor-alpha, and interleukin-6 with chronic kidney disease.
Lee BT; Ahmed FA; Hamm LL; Teran FJ; Chen CS; Liu Y; Shah K; Rifai N; Batuman V; Simon EE; He J; Chen J
BMC Nephrol; 2015 May; 16():77. PubMed ID: 26025192
[TBL] [Abstract][Full Text] [Related]
8. Genetic damage in patients with chronic kidney disease, peritoneal dialysis and haemodialysis: a comparative study.
Rangel-López A; Paniagua-Medina ME; Urbán-Reyes M; Cortes-Arredondo M; Alvarez-Aguilar C; López-Meza J; Ochoa-Zarzosa A; Lindholm B; García-López E; Paniagua JR
Mutagenesis; 2013 Mar; 28(2):219-25. PubMed ID: 23408844
[TBL] [Abstract][Full Text] [Related]
9. The evaluation of oxidative stress and inflammation markers in serum and saliva of the patients with temporomandibular disorders.
Kazan D; Baş Akkor B; Aksoy A; Atmaca E
Turk J Med Sci; 2023; 53(6):1690-1696. PubMed ID: 38813510
[TBL] [Abstract][Full Text] [Related]
10. Determination of oxidative stress and cellular inflammation in patients with diabetic nephropathy and non-diabetic nephropathy being administered hemodialysis treatment due to chronic renal failure.
Avci E; Cakir E; Cevher SC; Yaman H; Agilli M; Bilgi C
Ren Fail; 2014 Jun; 36(5):767-73. PubMed ID: 24579657
[TBL] [Abstract][Full Text] [Related]
11. Inflammation and oxidation: do they improve after kidney transplantation? Relationship with mortality after transplantation.
Cañas L; Iglesias E; Pastor MC; Barallat J; Juega J; Bancu I; Lauzurica R
Int Urol Nephrol; 2017 Mar; 49(3):533-540. PubMed ID: 28013471
[TBL] [Abstract][Full Text] [Related]
12. Association between albuminuria, kidney function, and inflammatory biomarker profile in CKD in CRIC.
Gupta J; Mitra N; Kanetsky PA; Devaney J; Wing MR; Reilly M; Shah VO; Balakrishnan VS; Guzman NJ; Girndt M; Periera BG; Feldman HI; Kusek JW; Joffe MM; Raj DS;
Clin J Am Soc Nephrol; 2012 Dec; 7(12):1938-46. PubMed ID: 23024164
[TBL] [Abstract][Full Text] [Related]
13. Inflammation and elevated levels of fibroblast growth factor 23 are independent risk factors for death in chronic kidney disease.
Munoz Mendoza J; Isakova T; Cai X; Bayes LY; Faul C; Scialla JJ; Lash JP; Chen J; He J; Navaneethan S; Negrea L; Rosas SE; Kretzler M; Nessel L; Xie D; Anderson AH; Raj DS; Wolf M;
Kidney Int; 2017 Mar; 91(3):711-719. PubMed ID: 28017325
[TBL] [Abstract][Full Text] [Related]
14. Inflammation and Progression of CKD: The CRIC Study.
Amdur RL; Feldman HI; Gupta J; Yang W; Kanetsky P; Shlipak M; Rahman M; Lash JP; Townsend RR; Ojo A; Roy-Chaudhury A; Go AS; Joffe M; He J; Balakrishnan VS; Kimmel PL; Kusek JW; Raj DS;
Clin J Am Soc Nephrol; 2016 Sep; 11(9):1546-1556. PubMed ID: 27340285
[TBL] [Abstract][Full Text] [Related]
15. High-sensitivity C-reactive protein and the risk of chronic kidney disease progression or acute kidney injury in post-myocardial infarction patients.
Fu EL; Franko MA; Obergfell A; Dekker FW; Gabrielsen A; Jernberg T; Carrero JJ
Am Heart J; 2019 Oct; 216():20-29. PubMed ID: 31382219
[TBL] [Abstract][Full Text] [Related]
16. Association of serum lncRNA H19 expression with inflammatory and oxidative stress markers and routine biochemical parameters in chronic kidney disease.
Okuyan HM; Dogan S; Terzi MY; Begen MA; Turgut FH
Clin Exp Nephrol; 2021 May; 25(5):522-530. PubMed ID: 33548016
[TBL] [Abstract][Full Text] [Related]
17. Associations between urinary phenol and paraben concentrations and markers of oxidative stress and inflammation among pregnant women in Puerto Rico.
Watkins DJ; Ferguson KK; Anzalota Del Toro LV; Alshawabkeh AN; Cordero JF; Meeker JD
Int J Hyg Environ Health; 2015 Mar; 218(2):212-9. PubMed ID: 25435060
[TBL] [Abstract][Full Text] [Related]
18. Biomarkers of Cardiovascular Disease and Mortality Risk in Patients with Advanced CKD.
Sun J; Axelsson J; Machowska A; Heimbürger O; Bárány P; Lindholm B; Lindström K; Stenvinkel P; Qureshi AR
Clin J Am Soc Nephrol; 2016 Jul; 11(7):1163-1172. PubMed ID: 27281698
[TBL] [Abstract][Full Text] [Related]
19. Impact of cardiovascular risk factors and inflammatory status on urinary 8-OHdG in essential hypertension.
Roselló-Lletí E; de Burgos FG; Morillas P; Cortés R; Martínez-Dolz L; Almenar L; Grigorian L; Orosa P; Portolés M; Bertomeu V; Rivera M
Am J Hypertens; 2012 Feb; 25(2):236-42. PubMed ID: 22052073
[TBL] [Abstract][Full Text] [Related]
20. Plasma concentrations of 8-hydroxy-2'-deoxyguanosine and risk of kidney disease and death in individuals with type 1 diabetes.
Sanchez M; Roussel R; Hadjadj S; Moutairou A; Marre M; Velho G; Mohammedi K
Diabetologia; 2018 Apr; 61(4):977-984. PubMed ID: 29185011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
